Cambridge Pharma Limited

Cambridge Pharma Limited is an expert in small-batch sterile fill-finish, based in Cambridge, UK

At Cambridge Pharma we specialise in filling batches of 100 to 10,000 units for a range of presentations, including vials, syringes and cartridges as well as custom primary drug containers.

Our state-of-the-art cGMP facility is designed to provide the highest levels of sterility assurance and quality control. It’s equipped to work with small molecules, cytotoxic formulations and large molecules (non-active biologics), and can handle a wide range of solution viscosities, suspensions and gels.

Alongside our cGMP manufacturing facility, our pilot and analytical laboratories allow our experienced scientific team to carry out process development work, analytical method transfer and validation, QC release and stability testing, and, if required, QP release to clinic.

Cambridge Pharma is part of the SMC group which also includes SMC Ltd Contract Manufacturing, based in the USA, and Oval Medical Technologies Ltd, which is based in Cambridge, UK.

The SMC Group utilises the strengths of its three associated companies to provide both new technologies in drug delivery and contract pharmaceutical development services to provide a full end-to-end solution for its customers.

SMC Ltd Contract Manufacturing is a contract manufacturer that is focused solely in manufacturing products for the healthcare industry. Its teams specialise in launching medical devices, diagnostic product, and drug delivery devices.

Oval Medical Technologies specialises in the development of patient-centric autoinjectors that meet the most challenging requirements arising from diverse patient groups and novel drug formulations. Oval’s approach is built around two key areas; establishing a deep understanding of the cognitive, physical and emotional needs of each patient group; and the comprehensive characterisation of formulation behaviours under a range of conditions. With Oval’s experience in developing novel primary drug containers, which enables true design freedom, this approach allows us to customise our advanced autoinjector technologies to create truly optimised devices which drives patient choice and sustainable competitive advantage.

Stay up to date with Cambridge Pharma Limited

Login or create a free user account to follow this company and see updates on your dashboard.

Create account